Rebecca Lockwood
Family · Asheville, NCNPI 1982940417
Payments from drug & device makers
Across 222 payments — averaging $22.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Novo Nordisk$691
- AstraZeneca$512
- Dexcom, Inc.$435
- Insulet Corporation$343
- Tandem Diabetes Care, Inc.$258
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,059100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 55 | $1,145 |
| Novo Nordisk | 33 | $691 |
| AstraZeneca | 23 | $512 |
| Dexcom, Inc. | 15 | $435 |
| Insulet Corporation | 7 | $343 |
| Tandem Diabetes Care, Inc. | 11 | $258 |
| Bayer | 7 | $244 |
| AbbVie | 9 | $166 |
| Boehringer Ingelheim | 12 | $163 |
| BETA Bionics, Inc. | 2 | $160 |
| Sanofi-aventis U.S. LLC | 8 | $151 |
| Medtronic | 5 | $142 |
| BD | 4 | $89 |
| Abbott | 4 | $78 |
| IBSA Pharma Inc. | 5 | $70 |
| Lifescan, Inc. | 3 | $70 |
| Xeris Pharmaceuticals, Inc. | 3 | $65 |
| Amgen(2 entities) | 3 | $56 |
| Corcept Therapeutics | 3 | $55 |
| Amarin Pharma, Inc. | 2 | $42 |
| Amneal Pharmaceuticals LLC | 2 | $32 |
| EUSA Pharma (US) LLC | 1 | $23 |
| Recordati_rare_diseases_inc. | 1 | $23 |
| Amryt Pharma Holdings Ltd | 1 | $19 |
| Cequr Corporation | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| GRT US Holding, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$375
- Wegovy$240
- DEXCOM G6 TRANSMITTER$129
- FARXIGA$125
- Kerendia$125
- MOUNJARO$103
How this compares
$5,073 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 134 | $205,687 |
| MounjaroTirzepatide | 64 | $136,281 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 96 | $131,124 |
| Humalog Kwikpen U-200Insulin Lispro | 30 | $108,444 |
| Tresiba Flextouch U-200Insulin Degludec | 55 | $88,696 |
| Tresiba Flextouch U-100Insulin Degludec | 114 | $80,710 |
| JardianceEmpagliflozin | 53 | $60,044 |
| TrulicityDulaglutide | 33 | $55,512 |
| FiaspInsulin Aspart (Niacinamide) | 25 | $47,727 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 42 | $40,120 |
| Gvoke Hypopen 2-PackGlucagon | 27 | $18,070 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 21 | $17,824 |
| LyumjevInsulin Lispro-Aabc | 15 | $17,510 |
| FarxigaDapagliflozin Propanediol | 23 | $13,550 |
| NovologInsulin Aspart | 41 | $12,926 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Fiasp, Novolog | $691 | $266,341200 claims |
| Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Humalog, Insulin Lispro | $1,145 | $222,687156 claims |
| Boehringer IngelheimJardiance | $163 | $60,04453 claims |
| AstraZenecaFarxiga | $512 | $13,55023 claims |
| AbbVieSynthroid | $166 | $1,97321 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $32 | $98888 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.
Other family in Asheville
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.